Clinical Nutrition Market : Current Scenario and Forecast (2020-2026): Emphasis on Product (Infant nutrition (Milk-based, Soy-based, Specialized), Enteral nutrition (Standard Fiber Containing, Elemental, Specialized), Parenteral Nutrition (Amino Acid, Dextrose, Fats, Additives)), End-User (Pediatric, Adult, Baby Boomers), Distribution Channel (Convenience Stores, Supermarket/Hypermarket, Drug store, Online Channel) and Region/Country
- UNI4065909
- 220 Pages
- February 2020
- Consumer Goods
“Amongst product type, Infant Nutrition dominated the market in 2019, generating revenue of US$ 23.07 billion”
Based on product Type, the market is fragmented into infant, enteral nutrition and parenteral nutrition. Infant Nutrition segment occupied the maximum share in Global clinical nutrition market. Adequate nutrition during infancy is essential for lifelong health and wellbeing. Enteral Nutrition segment is expected to witness CAGR growth of 3.8% during the forecast period 2020-2026.
“Amongst Infant nutrition, Milk Based products are projected to be the largest market throughout the forecast period”
Global infant nutrition market is bifurcated into milk-based, soy-based and specialized. In 2019, Milk Based Infant nutrition products dominated the market, with 55.9% share. Milk Based Infant nutrition products are altered to resemble breast milk. The formula is designed in order to make it easier to digest and with right amount of nutrients.
“Standard Fiber Containing Enteral nutrition product dominated the Enteral nutrition segment market in 2019”
Enteral nutrition segment is further bifurcated into standard fiber containing, elemental and specialized. In 2019, Standard Fiber Containing segment held the lead share. Enteral nutrition is preferred route for the nutritional support of critically ill patients under intensive care. Fiber use essentially used in patients suffering from diarrhea and other gastrointestinal symptoms such as abdominal distension, gastric residual volume, vomiting and constipation.
“Amino Acid Parenteral nutrition product dominated the Parenteral nutrition segment market in 2019”
Parenteral nutrition segment is further fragmented into amino acid, dextrose, fats and additives. Amino Acid occupied the maximum share of 52.7% in 2019. Parenteral nutrition solutions are composed of mixed amino acid products providing essential amino acids along with nonessential amino acids in varying composition.
“Adult population were the largest consumer of Clinical Nutritional products globally”
Based on end-user, the market is bifurcated into pediatric, adult and Baby Boomers. Adult population segment dominated the market with 65.58% share however, baby boomer segment is expected to witness highest CAGR growth of 5.1% during the forecast period 2020-2026. Clinical nutrition is prescribed to the adults suffering from several disorders such as gastrointestinal diseases, diarrhea and to support cell, organ and skeletal, cardiac and respiratory muscle functions, and wound healing.
“Amongst Distribution channel, Drug store was the most preferred sales channel for Clinical Nutrition”
Based on the Distribution channel, the global clinical nutrition market is segmented into convenience stores, supermarket/hypermarket, drug store and online channel. Sales of clinical nutrition through Drug store generated revenue of US$ 16.67 billion in 2019. However, online sales channel is expected to witness highest CAGR growth of 6.1% during the forecast period.
“Asia-Pacific represents as one of the largest markets of Global clinical nutrition market.”
For a deep dive analysis of the clinical nutrition market, detailed analysis was conducted for major regions/countries including North America (the U.S, Canada and rest of North America), Europe (Germany, the U.K., France and rest of Europe), Asia-Pacific (Japan, India, China, Indonesia, Pakistan and Rest of Asia-Pacific), and Rest of the World. In 2019, Asia-Pacific dominated the market, due to the factors such as rising health awareness and increasing geriatric population. Asia-Pacific is expected to generate revenue of US$ 26.54 billion by 2026.
Competitive Landscape-Top 15 Market Players
B. Braun Melsungen AG, Baxter Healthcare, Perrigo, Fresenius Kabi, Pfizer, Nestle, Ajinomoto, Co. Inc., Abbott, Danone, Glanbia, Plc, Lonza Group Ltd., Nutricia North America, Meiji Holdings Co., Ltd., GlaxoSmithKline, H. J. Heinz Company are some of the prominent players operating in the Global clinical nutrition market industry. North America is anticipated to show the maximum growth. Several M&A’s along with partnerships have been undertaken by these players to facilitate costumers with hi-tech and innovative products.
Reasons to buy:
• Current and future market size from 2018 to 2026 in terms of value (US$)
• Combined analysis of deep dive secondary research and input from primary research through Key Opinion Leaders of the industry
• Country level details of the overall adoption of Clinical Nutrition market
• A quick review of overall industry performance at a glance
• An In-depth analysis of key industry players
• A detailed analysis of regulatory framework, drivers, restraints, key trends and opportunities prevailing in the industry
• Examination of industry attractiveness with the help of Porter’s Five Forces analysis and start ups
• The study comprehensively covers the market across different segments and sub-segments of the technology
• Regions/countries Covered: North America (the U.S, Canada and rest of North America), Europe (Germany, the U.K., France and rest of Europe), Asia-Pacific (Japan, India, China, Indonesia, Pakistan and Rest of Asia-Pacific), and Rest of the World
Customization Options:
UMI understands that you may have your own business need, hence we also provide fully customized solutions to clients. The Global Clinical Nutrition Market can be customized to country level or any other market segment.
1.1 Market Definition 23
1.2 Objective of the Study 23
1.3 Limitation 23
1.4 Stakeholders 24
1.5 Currency used in the Report 24
1.6 Scope of the Global Clinical Nutrition Market Study 24
2. RESEARCH METHODOLOGY OR ASSUMPTION 25
2.1 Research Methodology for the Clinical nutrition Market Study 25
2.1.1 Main objective of the Clinical nutrition Market Study 26
3. INDUSTRY PERFORMANCE 27
4. EXECUTIVE SUMMARY 29
5. MARKET OVERVIEW 31
5.1 Introduction 31
5.2 Market Dynamics 32
5.2.1 Market Trend & Drivers 32
5.2.1.1 Escalating Geriatric Population 32
5.2.1.2 Rising Incidence of Lifestyle-Related Disorders 32
5.2.1.3 Declining Fertility Rates 33
5.2.1.4 Improving Health Standards and Increasing Health Expenditure 33
5.2.1.5 Rise in the Count of Children Suffering from Malnutrition 33
5.2.2 Market Challenges 34
5.2.2.1 Lack of Awareness Regarding Clinical Nutrition 34
5.2.2.2 Stringent Government Regulations 34
5.2.3 Market Opportunities 35
5.2.3.1 Rising Demand of Clinical Nutrition in Pediatrics 35
5.2.3.2 Rising Adoption of Online Retailing 35
6. LEGAL & REGULATORY FRAMEWORK 36
6.1 General Overview 36
6.1.1 United States 36
7. DEMAND AND SUPPLY SIDE ANALYSIS 37
7.1 Demand Side Analysis 37
7.2 Supply Side Analysis 37
7.2.1 Top Partnerships 38
7.2.2 Top Mergers & Acquisitions 38
7.2.3 Top Funding 38
7.2.4 Top Business Expansion 38
7.2.5 Top Product Launches 38
7.2.6 Top Start-ups under Clinical Nutrition Industry 39
8. VALUE CHAIN ANALYSIS 40
8.1 Value Chain Analysis 40
9. MARKET INSIGHTS BY PRODUCT TYPE 41
9.1 General Overview 41
9.1.1 Infant Nutrition 42
9.1.1.1 Milk Based Infant Nutrition 43
9.1.1.2 Soy Based Infant Nutrition 43
9.1.1.3 Specialized Infant Nutrition 45
9.1.2 Enteral Nutrition 46
9.1.2.1 Standard Fiber Containing 46
9.1.2.2 Elemental Nutrition 47
9.1.2.3 Specialized 49
9.1.3 Parenteral Nutrition 50
9.1.3.1 Amino Acid 50
9.1.3.2 Dextrose 51
9.1.3.3 Fats 53
9.1.3.4 Additives 54
10. MARKET INSIGHTS BY END-USER 55
10.1 General Overview 55
10.1.1 Adults 56
10.1.2 Pediatric 57
10.1.3 Baby Boomer 57
11. MARKET INSIGHTS BY DISTRIBUTION CHANNEL 59
11.1 General Overview 59
11.1.1 Convenience Stores 60
11.1.2 Supermarket/Hypermarket 61
11.1.3 Drug store 62
11.1.4 Others (Online) 63
12. MARKET INSIGHTS BY REGION 64
12.1 General Overview 64
12.2 North America Clinical Nutrition Market 65
12.2.1 North America Clinical Nutrition Market, by Product Type 65
12.2.1.1 North America Infant Nutrition Market, by Product Type 66
12.2.1.2 North America Enteral Nutrition Market, by Product Type 66
12.2.1.3 North America Parenteral Nutrition Market, by Product Type 67
12.2.2 North America Clinical Nutrition Market, by End-User 68
12.2.3 North America Clinical Nutrition Market, by Distribution Channel 68
12.2.4 North America Clinical Nutrition Market, by Country 69
12.2.4.1 US Clinical Nutrition Market 69
12.2.4.1.1 US Clinical Nutrition Market, by Product Type 70
12.2.4.1.2 US Infant Nutrition Market, by Product Type 70
12.2.4.1.3 US Enteral Nutrition Market, by Product Type 71
12.2.4.1.4 US Parenteral Nutrition Market, by Product Type 72
12.2.4.1.5 US Clinical Nutrition Market, by End-User 72
12.2.4.1.6 US Clinical Nutrition Market, by Distribution Channel 73
12.2.4.2 Canada Clinical Nutrition Market 73
12.2.4.2.1 Canada Clinical Nutrition Market, by Product Type 74
12.2.4.2.2 Canada Infant Nutrition Market, by Product Type 74
12.2.4.2.3 Canada Enteral Nutrition Market, by Product Type 75
12.2.4.2.4 Canada Parenteral Nutrition Market, by Product Type 76
12.2.4.2.5 Canada Clinical Nutrition Market, by End- User 76
12.2.4.2.6 Canada Clinical Nutrition Market, by Distribution Channel 77
12.2.4.3 Rest of North America Clinical Nutrition Market 77
12.2.4.3.1 Rest of North America Clinical Nutrition Market, by Product Type 78
12.2.4.3.2 Rest of North America Infant Nutrition Market, by Product Type 78
12.2.4.3.3 Rest of North America Enteral Nutrition Market, by Product Type 79
12.2.4.3.4 Rest of North America Parenteral Nutrition Market, by Product Type 80
12.2.4.3.5 Rest of North America Clinical Nutrition Market, by End-User 80
12.2.4.3.6 Rest of North America Clinical Nutrition Market, by Distribution Channel 81
12.3 Europe Clinical Nutrition Market 81
12.3.1 Europe Clinical Nutrition Market, by Product Type 82
12.3.2 Europe Infant Nutrition Market, by Product Type 82
12.3.3 Europe Enteral Nutrition Market, by Product Type 83
12.3.4 Europe Parenteral Nutrition Market, by Product Type 84
12.3.5 Europe Clinical Nutrition Market, by End-User 84
12.3.6 Europe Clinical Nutrition Market, by Distribution Channel 85
12.3.7 Europe Clinical Nutrition Market, by Country 85
12.3.7.1 Germany Clinical Nutrition Market 86
12.3.7.1.1 Germany Clinical Nutrition Market, by Product Type 86
12.3.7.1.2 Germany Infant Nutrition Market, by Product Type 87
12.3.7.1.3 Germany Enteral Nutrition Market, by Product Type 87
12.3.7.1.4 Germany Parenteral Nutrition Market, by Product Type 88
12.3.7.1.5 Germany Clinical Nutrition Market, by End- User 89
12.3.7.1.6 Germany Clinical Nutrition Market, by Distribution Channel 89
12.3.7.2 United Kingdom Clinical Nutrition Market 90
12.3.7.2.1 United Kingdom Clinical Nutrition Market, by Product Type 90
12.3.7.2.2 United Kingdom Infant Nutrition Market, by Product Type 91
12.3.7.2.3 United Kingdom Enteral Nutrition Market, by Product Type 91
12.3.7.2.4 United Kingdom Parenteral Nutrition Market, by Product Type 92
12.3.7.2.5 United Kingdom Clinical Nutrition Market, by End-User 93
12.3.7.2.6 United Kingdom Clinical Nutrition Market, by Distribution Channel 93
12.3.7.3 France Clinical Nutrition Market 94
12.3.7.3.1 France Clinical Nutrition Market, by Product Type 94
12.3.7.3.2 France Infant Nutrition Market, by Product Type 95
12.3.7.3.3 France Enteral Nutrition Market, by Product Type 95
12.3.7.3.4 France Parenteral Nutrition Market, by Product Type 96
12.3.7.3.5 France Clinical Nutrition Market, by End- User 97
12.3.7.3.6 France Clinical Nutrition Market, by Distribution Channel 97
12.3.7.4 Rest of the Europe Clinical Nutrition Market 98
12.3.7.4.1 Rest of the Europe Clinical Nutrition Market, by Product Type 98
12.3.7.4.2 Rest of the Europe Infant Nutrition Market, by Product Type 99
12.3.7.4.3 Rest of the Europe Enteral Nutrition Market, by Product Type 99
12.3.7.4.4 Rest of the Europe Parenteral Nutrition Market, by Product Type 100
12.3.7.4.5 Rest of the Europe Clinical Nutrition Market, by End-User 101
12.3.7.4.6 Rest of the Europe Clinical Nutrition Market, by Distribution Channel 101
12.4 Asia-Pacific Clinical Nutrition Market 102
12.4.1 Asia-Pacific Clinical Nutrition Market, by Product Type 102
12.4.2 Asia-Pacific Infant Nutrition Market, by Product Type 103
12.4.3 Asia-Pacific Enteral Nutrition Market, by Product Type 103
12.4.4 Asia-Pacific Parenteral Nutrition Market, by Product Type 104
12.4.5 Asia-Pacific Clinical Nutrition Market, by End-User 105
12.4.6 Asia-Pacific Clinical Nutrition Market, by Distribution Channel 105
12.4.7 Asia-Pacific Clinical Nutrition Market, by Country 106
12.4.7.1 China Clinical Nutrition Market 106
12.4.7.1.1 China Clinical Nutrition Market, by Product Type 107
12.4.7.1.2 China Infant Nutrition Market, by Product Type 107
12.4.7.1.3 China Enteral Nutrition Market, by Product Type 108
12.4.7.1.4 China Parenteral Nutrition Market, by Product Type 109
12.4.7.1.5 China Clinical Nutrition Market, by End- User 109
12.4.7.1.6 China Clinical Nutrition Market, by Distribution Channel 110
12.4.7.2 India Clinical Nutrition Market 110
12.4.7.2.1 India Clinical Nutrition Market, by Product Type 111
12.4.7.2.2 India Infant Nutrition Market, by Product Type 111
12.4.7.2.3 India Enteral Nutrition Market, by Product Type 112
12.4.7.2.4 India Parenteral Nutrition Market, by Product Type 113
12.4.7.2.5 India Clinical Nutrition Market, by End-User 113
12.4.7.2.6 India Clinical Nutrition Market, by Distribution Channel 114
12.4.7.3 Japan Clinical Nutrition Market 114
12.4.7.3.1 Japan Clinical Nutrition Market, by Product Type 115
12.4.7.3.2 Japan Infant Nutrition Market, by Product Type 115
12.4.7.3.3 Japan Enteral Nutrition Market, by Product Type 116
12.4.7.3.4 Japan Parenteral Nutrition Market, by Product Type 117
12.4.7.3.5 Japan Clinical Nutrition Market, by End- User 117
12.4.7.3.6 Japan Clinical Nutrition Market, by Distribution Channel 118
12.4.7.4 Indonesia Clinical Nutrition Market 118
12.4.7.4.1 Indonesia Clinical Nutrition Market, by Product Type 119
12.4.7.4.2 Indonesia Infant Nutrition Market, by Product Type 119
12.4.7.4.3 Indonesia Enteral Nutrition Market, by Product Type 120
12.4.7.4.4 Indonesia Parenteral Nutrition Market, by Product Type 121
12.4.7.4.5 Indonesia Clinical Nutrition Market, by End-User 121
12.4.7.4.6 Indonesia Clinical Nutrition Market, by Distribution Channel 122
12.4.7.5 Pakistan Clinical Nutrition Market 122
12.4.7.5.1 Pakistan Clinical Nutrition Market, by Product Type 123
12.4.7.5.2 Pakistan Infant Nutrition Market, by Product Type 123
12.4.7.5.3 Pakistan Enteral Nutrition Market, by Product Type 124
12.4.7.5.4 Pakistan Parenteral Nutrition Market, by Product Type 125
12.4.7.5.5 Pakistan Clinical Nutrition Market, by End-User 125
12.4.7.5.6 Pakistan Clinical Nutrition Market, by Distribution Channel 126
12.4.7.6 Rest of the APAC Clinical Nutrition Market 126
12.4.7.6.1 Rest of the APAC Clinical Nutrition Market, by Product Type 127
12.4.7.6.2 Rest of the APAC Infant Nutrition Market, by Product Type 127
12.4.7.6.3 Rest of the APAC Enteral Nutrition Market, by Product Type 128
12.4.7.6.4 Rest of the APAC Parenteral Nutrition Market, by Product Type 129
12.4.7.6.5 Rest of the APAC Clinical Nutrition Market, by End- User 129
12.4.7.6.6 Rest of the APAC Clinical Nutrition Market, by Distribution Channel 130
12.5 Rest of World Clinical Nutrition Market 130
12.5.1 Rest of World Clinical Nutrition Market, by Product Type 131
12.5.2 Rest of World Infant Nutrition Market, by Product Type 131
12.5.3 Rest of World Enteral Nutrition Market, by Product Type 132
12.5.4 Rest of World Parenteral Nutrition Market, by Product Type 133
12.5.5 Rest of World Clinical Nutrition Market, by End-User 133
12.5.6 Rest of World Clinical Nutrition Market, by Distribution Channel 134
13. COMPETITIVE SCENARIO 135
13.1 Porter’s Five forces analysis 135
13.1.1 Bargaining power of Supplier 136
13.1.2 Bargaining power of Buyer 136
13.1.3 Industry Rivalry 136
13.1.4 Availability of Substitute 136
13.1.5 Threat of new Entrants 137
13.2 Competitive Landscape 137
13.2.1 Market Share of Key Players in Clinical Nutrition Market, 2019 138
14. TOP COMPANY PROFILES 139
14.1 DANONE S.A North America, Inc. 139
14.1.1 Key Facts 139
14.1.2 Business Description 139
14.1.3 Key Product/Services Offerings 140
14.1.4 Growth Strategy 140
14.1.5 SWOT Analysis 142
14.1.6 Key Financials 143
14.1.6.1 Revenue Split, by Region and Segment 144
14.1.7 Recent Developments 144
14.1.7.1 Product Launches 144
14.1.7.2 Partnerships 144
14.1.7.3 Mergers and Acquisitions 145
14.2 B. Braun Melsungen AG 146
14.2.1 Key Facts 146
14.2.2 Business Description 146
14.2.3 Key Product/Services Offerings 146
14.2.4 Growth Strategy 147
14.2.5 SWOT Analysis 147
14.2.6 Key Financials 148
14.2.6.1 Revenue Split 149
14.2.6.2 Financial Overview of B. Braun Melsungen AG 149
14.2.7 Recent Developments 150
14.2.7.1 Product Launches 150
14.2.7.2 AeroVironment Inc Partnerships (Strategic Alliance) 150
14.2.7.3 Business Expansions 150
14.2.7.4 Mergers & Acquisitions 150
14.3 Baxter Healthcare 151
14.3.1 Key Facts 151
14.3.2 Business Description 151
14.3.3 Key Product/Services Offerings 151
14.3.4 Growth Strategy 152
14.3.5 SWOT Analysis 152
14.3.6 Key Financials 153
14.3.6.1 Revenue Split 154
14.3.6.2 Financial Overview of Baxter Healthcare 154
14.3.7 Recent Developments 155
14.3.7.1 Product Launches 155
14.3.7.2 Partnerships (Strategic Alliance) 155
14.3.7.3 Business Expansions 155
14.3.7.4 Mergers& Acquisitions 155
14.4 Perrigo 156
14.4.1 Key Facts 156
14.4.2 Business Description 156
14.4.3 Key Product/Services Offerings 156
14.4.4 Growth Strategy 157
14.4.5 SWOT Analysis 157
14.4.6 Key Financials 158
14.4.6.1 Revenue Split 159
14.4.6.2 Financial Overview of Perrigo 159
14.4.7 Recent Developments 160
14.4.7.1 Product Launches 160
14.4.7.2 Partnerships (Strategic Alliance) 160
14.4.7.3 Business Expansions 160
14.4.7.4 Mergers& Acquisitions 160
14.5 Fresenius Kabi 161
14.5.1 Key Facts 161
14.5.2 Business Description 161
14.5.3 Key Product/Services Offerings 161
14.5.4 Growth Strategy 162
14.5.5 SWOT Analysis 162
14.5.6 Key Financials 163
14.5.6.1 Revenue Split 164
14.5.6.2 Financial Overview of Fresenius Kabi 164
14.5.7 Recent Developments 165
14.5.7.1 Product Launches 165
14.5.7.2 Partnerships (Strategic Alliance) 165
14.5.7.3 Business Expansions 165
14.5.7.4 Mergers& Acquisitions 165
14.6 Pfizer 166
14.6.1 Key Facts 166
14.6.2 Business Description 166
14.6.3 Key Product/Services Offerings 166
14.6.4 Growth Strategy 167
14.6.5 SWOT Analysis 167
14.6.6 Key Financials 168
14.6.6.1 Revenue Split 169
14.6.6.2 Financial Overview of Pfizer 169
14.6.7 Recent Developments 170
14.6.7.1 Product Launches 170
14.6.7.2 Partnerships (Strategic Alliance) 170
14.6.7.3 Business Expansions 170
14.6.7.4 Mergers& Acquisitions 170
14.7 Nestlé 171
14.7.1 Key Facts 171
14.7.2 Business Description 171
14.7.3 Key Product/Services Offerings 171
14.7.4 Growth Strategy 172
14.7.5 SWOT Analysis 172
14.7.6 Key Financials 173
14.7.6.1 Revenue Split 174
14.7.6.2 Financial Overview of Nestlé 174
14.7.7 Recent Developments 175
14.7.7.1 Product Launches 175
14.7.7.2 Partnerships (Strategic Alliance) 175
14.7.7.3 Business Expansions 175
14.7.7.4 Mergers& Acquisitions 175
14.8 Ajinomoto Co. Inc. 176
14.8.1 Key Facts 176
14.8.2 Business Description 176
14.8.3 Key Product/Services Offerings 176
14.8.4 Growth Strategy 177
14.8.5 SWOT Analysis 177
14.8.6 Key Financials 178
14.8.6.1 Revenue Split 179
14.8.6.2 Financial Overview of Ajinomoto Co. Inc. 179
14.8.7 Recent Developments 180
14.8.7.1 Product Launches 180
14.8.7.2 Partnerships (Strategic Alliance) 180
14.8.7.3 Business Expansions 180
14.8.7.4 Mergers& Acquisitions 180
14.9 Glanbia, Plc 181
14.9.1 Key Facts 181
14.9.2 Business Description 181
14.9.3 Key Product/Services Offerings 181
14.9.4 Growth Strategy 182
14.9.5 SWOT Analysis 182
14.9.6 Key Financials 183
14.9.6.1 Revenue Split 184
14.9.6.2 Financial Overview of Glanbia, Plc 184
14.9.7 Recent Developments 185
14.9.7.1 Product Launches 185
14.9.7.2 Partnerships (Strategic Alliance) 185
14.9.7.3 Business Expansions 185
14.9.7.4 Mergers& Acquisitions 185
14.10 Abbott 186
14.10.1 Key Facts 186
14.10.2 Business Description 186
14.10.3 Key Product/Services Offerings 186
14.10.4 Growth Strategy 187
14.10.5 SWOT Analysis 187
14.10.6 Key Financials 188
14.10.6.1 Revenue Split 189
14.10.6.2 Financial Overview of Abbott 189
14.10.7 Recent Developments 190
14.10.7.1 Product Launches 190
14.10.7.2 Partnerships (Strategic Alliance) 190
14.10.7.3 Business Expansions 190
14.10.7.4 Mergers& Acquisitions 190
14.11 Lonza Group Ltd. 191
14.11.1 Key Facts 191
14.11.2 Business Description 191
14.11.3 Key Product/Services Offerings 191
14.11.4 Growth Strategy 192
14.11.5 SWOT Analysis 192
14.11.6 Key Financials 193
14.11.6.1 Revenue Split 194
14.11.6.2 Financial Overview of Lonza Group Ltd. 194
14.11.7 Recent Developments 195
14.11.7.1 Product Launches 195
14.11.7.2 Partnerships (Strategic Alliance) 195
14.11.7.3 Business Expansions 195
14.11.7.4 Mergers& Acquisitions 195
14.12 GlaxoSmithKline 196
14.12.1 Key Facts 196
14.12.2 Business Description 196
14.12.3 Key Product/Services Offerings 196
14.12.4 Growth Strategy 197
14.12.5 SWOT Analysis 197
14.12.6 Key Financials 198
14.12.6.1 Revenue Split 199
14.12.6.2 Financial Overview of GlaxoSmithKline 199
14.12.7 Recent Developments 200
14.12.7.1 Product Launches 200
14.12.7.2 Partnerships (Strategic Alliance) 200
14.12.7.3 Business Expansions 200
14.12.7.4 Mergers& Acquisitions 200
14.13 Meiji Holdings Co., Ltd. 201
14.13.1 Key Facts 201
14.13.2 Business Description 201
14.13.3 Key Product/Services Offerings 201
14.13.4 Growth Strategy 202
14.13.5 SWOT Analysis 202
14.13.6 Key Financials 203
14.13.6.1 Revenue Split 204
14.13.6.2 Financial Overview of Meiji Holdings Co., Ltd. 204
14.13.7 Recent Developments 205
14.13.7.1 Product Launches 205
14.13.7.2 Partnerships (Strategic Alliance) 205
14.13.7.3 Business Expansions 205
14.13.7.4 Mergers& Acquisitions 205
14.14 Nutricia North America 206
14.14.1 Key Facts 206
14.14.2 Business Description 206
14.14.3 Key Product/Services Offerings 206
14.14.4 Growth Strategy 207
14.14.5 SWOT Analysis 207
14.14.6 Key Financials 208
14.14.6.1 Revenue Split 209
14.14.6.2 Financial Overview of Nutricia North America 209
14.14.7 Recent Developments 210
14.14.7.1 Product Launches 210
14.14.7.2 Partnerships (Strategic Alliance) 210
14.14.7.3 Business Expansions 210
14.14.7.4 Mergers& Acquisitions 210
14.15 H. J. Heinz Company 211
14.15.1 Key Facts 211
14.15.2 Business Description 211
14.15.3 Key Product/Services Offerings 211
14.15.4 Growth Strategy 212
14.15.5 SWOT Analysis 212
14.15.6 Key Financials 213
14.15.6.1 Revenue Split 214
14.15.6.2 Financial Overview of H. J. Heinz Company 214
14.15.7 Recent Developments 215
14.15.7.1 Product Launches 215
14.15.7.2 Partnerships (Strategic Alliance) 215
14.15.7.3 Business Expansions 215
14.15.7.4 Mergers& Acquisitions 215
TABLE 2 Top Mergers& Acquisitions 38
TABLE 3 Top Funding 38
TABLE 4 Top Business Expansion 38
TABLE 5 Top Product Launches 38
TABLE 6 DANONE S.A North America, Inc. Key Facts 139
TABLE 7 DANONE SA Ownership Structure 139
TABLE 8 Product segmentation of DANONE S.A North America, Inc. 140
TABLE 9 DANONE S.A North America, Inc. Growth Strategy 140
TABLE 10 DANONE S.A North America, Inc. Product Launches 144
TABLE 11 DANONE S.A North America, Inc. Partnerships 144
TABLE 12 DANONE S.A North America, Inc. Mergers and Acquisitions 145
TABLE 13 B. Braun Melsungen AG Key Facts 146
TABLE 14 Product segmentation of B. Braun Melsungen AG 146
TABLE 15 B. Braun Melsungen AG Product Launches 150
TABLE 16 B. Braun Melsungen AG Partnerships 150
TABLE 17 B. Braun Melsungen AG Business Expansions 150
TABLE 18 B. Braun Melsungen AG Mergers and Acquisitions 150
TABLE 19 Baxter Healthcare Key Facts 151
TABLE 20 Product segmentation of Baxter Healthcare 151
TABLE 21 Baxter Healthcare Product Launches 155
TABLE 22 Baxter Healthcare Partnerships 155
TABLE 23 Baxter Healthcare Business Expansions 155
TABLE 24 Baxter Healthcare Mergers and Acquisitions 155
TABLE 25 Perrigo Key Facts 156
TABLE 26 Product segmentation of Perrigo 156
TABLE 27 Perrigo Product Launches 160
TABLE 28 Perrigo Partnerships 160
TABLE 29 Perrigo Business Expansions 160
TABLE 30 Perrigo Mergers and Acquisitions 160
TABLE 31 Fresenius Kabi Key Facts 161
TABLE 32 Product segmentation of Fresenius Kabi 161
TABLE 33 Fresenius Kabi Product Launches 165
TABLE 34 Fresenius Kabi Partnerships 165
TABLE 35 Fresenius Kabi Business Expansions 165
TABLE 36 Fresenius Kabi Mergers and Acquisitions 165
TABLE 37 Pfizer Key Facts 166
TABLE 38 Product segmentation of Pfizer 166
TABLE 39 Pfizer Product Launches 170
TABLE 40 Pfizer Partnerships 170
TABLE 41 Pfizer Business Expansions 170
TABLE 42 Pfizer Mergers and Acquisitions 170
TABLE 43 Nestlé Key Facts 171
TABLE 44 Product segmentation of Nestlé 171
TABLE 45 Nestlé Product Launches 175
TABLE 46 Nestlé Partnerships 175
TABLE 47 Nestlé Business Expansions 175
TABLE 48 Nestlé Mergers and Acquisitions 175
TABLE 49 Ajinomoto Co. Inc. Key Facts 176
TABLE 50 Product segmentation of Ajinomoto Co. Inc. 176
TABLE 51 Ajinomoto Co. Inc. Product Launches 180
TABLE 52 Ajinomoto Co. Inc. Partnerships 180
TABLE 53 Ajinomoto Co. Inc. Business Expansions 180
TABLE 54 Ajinomoto Co. Inc. Mergers and Acquisitions 180
TABLE 55 Glanbia, Plc Key Facts 181
TABLE 56 Product segmentation of Glanbia, Plc 181
TABLE 57 Glanbia, Plc Product Launches 185
TABLE 58 Glanbia, Plc Partnerships 185
TABLE 59 Glanbia, Plc Business Expansions 185
TABLE 60 Glanbia, Plc Mergers and Acquisitions 185
TABLE 61 Abbott Key Facts 186
TABLE 62 Product segmentation of Abbott 186
TABLE 63 Abbott Product Launches 190
TABLE 64 Abbott Partnerships 190
TABLE 65 Abbott Business Expansions 190
TABLE 66 Abbott Mergers and Acquisitions 190
TABLE 67 Lonza Group Ltd. Key Facts 191
TABLE 68 Product segmentation of Lonza Group Ltd. 191
TABLE 69 Lonza Group Ltd. Product Launches 195
TABLE 70 Lonza Group Ltd. Partnerships 195
TABLE 71 Lonza Group Ltd. Business Expansions 195
TABLE 72 Lonza Group Ltd. Mergers and Acquisitions 195
TABLE 73 GlaxoSmithKline Key Facts 196
TABLE 74 Product segmentation of GlaxoSmithKline 196
TABLE 75 GlaxoSmithKline Product Launches 200
TABLE 76 GlaxoSmithKline Partnerships 200
TABLE 77 GlaxoSmithKline Business Expansions 200
TABLE 78 GlaxoSmithKline Mergers and Acquisitions 200
TABLE 79 Meiji Holdings Co., Ltd. Key Facts 201
TABLE 80 Product segmentation of Meiji Holdings Co., Ltd. 201
TABLE 81 Meiji Holdings Co., Ltd. Product Launches 205
TABLE 82 Meiji Holdings Co., Ltd. Partnerships 205
TABLE 83 Meiji Holdings Co., Ltd. Business Expansions 205
TABLE 84 Meiji Holdings Co., Ltd. Mergers and Acquisitions 205
TABLE 85 Nutricia North America Key Facts 206
TABLE 86 Product segmentation of Nutricia North America 206
TABLE 87 Nutricia North America Product Launches 210
TABLE 88 Nutricia North America Partnerships 210
TABLE 89 Nutricia North America Business Expansions 210
TABLE 90 Nutricia North America Mergers and Acquisitions 210
TABLE 91 H. J. Heinz Company Key Facts 211
TABLE 92 Product segmentation of H. J. Heinz Company 211
TABLE 93 H. J. Heinz Company Product Launches 215
TABLE 94 H. J. Heinz Company Partnerships 215
TABLE 95 H. J. Heinz Company Business Expansions 215
TABLE 96 H. J. Heinz Company Mergers and Acquisitions 215
Similar Reports
Refrigerated display cases are cabinets with glass surfaces for items, which require cooling or preservation. The cases are ideal for products requiring a regulated temperature to maintain the freshness. These are mostly used in retail stores and food & re...
- Publish Date: May 5, 2016
- $5370
Probiotics are microorganisms, such as bacteria and yeast, that are very useful to sustain the balance of intestinal microbial in human and animal body. Probiotic ingredients stimulate natural digestive juices and enzymes in the body to ensure proper functio...
- Publish Date: August 1, 2016
- $5370
Wearable technology refers to electronics devices that are designed to be worn anywhere around the body thereby enabling hands free operations. Wearable technology products have gained popularity over the past few years, with advancements in technology an...
- Publish Date: April 6, 2017
- $5370
